C3orf62 and cancer: MAPs are frequently found overexpressed in tumors, where they are thought to promote cancer progression and resistance to MT-targeting chemotherapy drugs in part by altering microtubule dynamics and stability and promoting chromosomal instability in mitosis [6]–[7].